ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 495,85
0,99%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Autonomix Medical Inc (AMIX)

  7. Autonomix Medical Inc (AMIX) Actualités

AMIX

Autonomix Medical (AMIX)

Autonomix Medical Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMIX
DateHeureSourceTitreSymboleSociété
18/06/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMIXAutonomix Medical Inc
18/06/202414h00GlobeNewswire Inc.Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical TrialNASDAQ:AMIXAutonomix Medical Inc
17/06/202422h05GlobeNewswire Inc.Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive OfficerNASDAQ:AMIXAutonomix Medical Inc
10/06/202414h00GlobeNewswire Inc.Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024NASDAQ:AMIXAutonomix Medical Inc
03/06/202414h15GlobeNewswire Inc.Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical TrialNASDAQ:AMIXAutonomix Medical Inc
31/05/202423h25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMIXAutonomix Medical Inc
31/05/202422h56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMIXAutonomix Medical Inc
31/05/202414h05GlobeNewswire Inc.Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:AMIXAutonomix Medical Inc
23/05/202415h15GlobeNewswire Inc.Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic CancerNASDAQ:AMIXAutonomix Medical Inc
14/05/202422h15GlobeNewswire Inc.Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell SeriesNASDAQ:AMIXAutonomix Medical Inc
25/04/202414h30GlobeNewswire Inc.Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary MicrochipNASDAQ:AMIXAutonomix Medical Inc
24/04/202415h00GlobeNewswire Inc.Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarNASDAQ:AMIXAutonomix Medical Inc
16/04/202415h00GlobeNewswire Inc.Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related PainNASDAQ:AMIXAutonomix Medical Inc
09/04/202414h30GlobeNewswire Inc.Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal DenervationNASDAQ:AMIXAutonomix Medical Inc
08/04/202414h30GlobeNewswire Inc.Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX TickerNASDAQ:AMIXAutonomix Medical Inc
27/03/202414h00GlobeNewswire Inc.Autonomix to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:AMIXAutonomix Medical Inc
20/03/202413h05GlobeNewswire Inc. Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024NASDAQ:AMIXAutonomix Medical Inc
19/03/202413h45GlobeNewswire Inc.Autonomix Appoints Jennifer Cook as Chief Business OfficerNASDAQ:AMIXAutonomix Medical Inc
14/03/202413h15GlobeNewswire Inc.Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketNASDAQ:AMIXAutonomix Medical Inc
06/03/202414h00GlobeNewswire Inc.Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketNASDAQ:AMIXAutonomix Medical Inc
29/02/202414h30GlobeNewswire Inc.Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical TrialNASDAQ:AMIXAutonomix Medical Inc
23/02/202414h50GlobeNewswire Inc.Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix OpportunityNASDAQ:AMIXAutonomix Medical Inc
22/02/202414h00GlobeNewswire Inc.Autonomix Secures Principal Investigators and Completes Clinical Training for First Human StudyNASDAQ:AMIXAutonomix Medical Inc
16/02/202414h00GlobeNewswire Inc.Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketNASDAQ:AMIXAutonomix Medical Inc
14/02/202414h05GlobeNewswire Inc.Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key MilestonesNASDAQ:AMIXAutonomix Medical Inc
06/02/202414h50GlobeNewswire Inc.Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer PainNASDAQ:AMIXAutonomix Medical Inc
01/02/202414h35GlobeNewswire Inc.Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street EventNASDAQ:AMIXAutonomix Medical Inc
31/01/202414h45GlobeNewswire Inc.Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024NASDAQ:AMIXAutonomix Medical Inc
30/01/202418h00GlobeNewswire Inc.Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolioNASDAQ:AMIXAutonomix Medical Inc
30/01/202415h05GlobeNewswire Inc.Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field UseNASDAQ:AMIXAutonomix Medical Inc
 Showing the most relevant articles for your search:NASDAQ:AMIX

Dernières Valeurs Consultées

BOV
ITSAG982
ITSAG982 Ex:9,72
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés